Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Hair growth phase in mice weakens certain immune responses.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Vitiligo and alopecia areata may have similar causes despite their differences.

Nonsegmental vitiligo is caused by the immune system attacking skin cells, often linked to other autoimmune diseases.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

DM and AA may share a common cause.

Enhancing immune response can improve cancer treatment effectiveness.

Alopecia areata may be caused by the immune system attacking hair follicles.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Hair loss treatment caused more hair loss in a man.